Personal Cfo Solutions, LLC Edwards Lifesciences Corp Transaction History

Personal Cfo Solutions, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$72.54 - $95.56 $152,914 - $201,440	2,108 New	2,108 $201,000
Q2 2023 Aug 10, 2023	BUY	$81.41 - $94.33 $184,719 - $214,034	2,269 New	2,269 $214,000
Q2 2022 Aug 05, 2022	SELL	$86.5 - $128.27 $165,388 - $245,252	-1,912 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$101.96 - $128.34 $23,246 - $29,261	-228 Reduced 10.65%	1,912 $225,000
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $18,721 - $22,999	176 Added 8.96%	2,140 $277,000
Q3 2021 Nov 18, 2021	BUY	$102.91 - $122.75 $202,115 - $241,081	1,964 New	1,964 $222,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Personal Cfo Solutions, LLC with notifications on news.